Ira Targoff to Polymyositis
This is a "connection" page, showing publications Ira Targoff has written about Polymyositis.
Connection Strength
1.898
-
Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase. Arthritis Rheum. 2007 Apr; 56(4):1295-303.
Score: 0.284
-
Idiopathic inflammatory myopathy: autoantibody update. Curr Rheumatol Rep. 2002 Oct; 4(5):434-41.
Score: 0.208
-
The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis. Semin Arthritis Rheum. 2018 12; 48(3):504-512.
Score: 0.151
-
Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis. Ann Rheum Dis. 2018 05; 77(5):714-719.
Score: 0.150
-
Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype. Medicine (Baltimore). 2017 Jan; 96(3):e5694.
Score: 0.140
-
Epitope analysis of the major reactive region of the 100-kd protein of PM-Scl autoantigen. Arthritis Rheum. 1996 Sep; 39(9):1588-95.
Score: 0.137
-
Immune manifestations of inflammatory muscle disease. Rheum Dis Clin North Am. 1994 Nov; 20(4):857-80.
Score: 0.120
-
Clinical and laboratory features distinguishing juvenile polymyositis and muscular dystrophy. Arthritis Care Res (Hoboken). 2013 Dec; 65(12):1969-75.
Score: 0.113
-
Humoral immunity in polymyositis/dermatomyositis. J Invest Dermatol. 1993 Jan; 100(1):116S-123S.
Score: 0.106
-
Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women. Arthritis Rheum. 2009 Aug; 60(8):2499-504.
Score: 0.084
-
Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies. Arthritis Rheum. 2008 Oct; 58(10):3239-46.
Score: 0.079
-
Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups. Arthritis Rheum. 2005 Aug; 52(8):2433-8.
Score: 0.063
-
Update on myositis-specific and myositis-associated autoantibodies. Curr Opin Rheumatol. 2000 Nov; 12(6):475-81.
Score: 0.046
-
Classification criteria for the idiopathic inflammatory myopathies. Curr Opin Rheumatol. 1997 Nov; 9(6):527-35.
Score: 0.037
-
Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. Arthritis Rheum. 1997 Jul; 40(7):1257-66.
Score: 0.036
-
Anti-PM/Scl autoantibodies in patients without clinical polymyositis or scleroderma. J Rheumatol. 1996 Oct; 23(10):1729-33.
Score: 0.034
-
Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis. Arthritis Rheum. 2013 Jul; 65(7):1934-41.
Score: 0.027
-
Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase. J Clin Invest. 1993 Jun; 91(6):2556-64.
Score: 0.027
-
Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore). 2005 Jul; 84(4):231-249.
Score: 0.016
-
Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease. Arthritis Rheum. 2003 Aug; 48(8):2285-93.
Score: 0.014
-
Anti-U5 small nuclear ribonucleoprotein (snRNP) antibodies: a rare anti-U snRNP specificity. Clin Immunol Immunopathol. 1996 Oct; 81(1):41-7.
Score: 0.009
-
Clinical significance of specific autoantibodies in juvenile dermatomyositis. J Rheumatol. 1996 Oct; 23(10):1794-7.
Score: 0.009
-
Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum. 1996 Aug; 26(1):459-67.
Score: 0.008